XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Stock-based Compensation Expense

Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company’s stock-based awards, was as follows:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Cost of revenue

 

$

146

 

 

$

(105

)

 

$

268

 

 

$

382

 

Selling and marketing

 

 

581

 

 

 

415

 

 

 

1,518

 

 

 

1,192

 

Research and development

 

 

395

 

 

 

329

 

 

 

1,068

 

 

 

926

 

General and administrative

 

 

1,086

 

 

 

859

 

 

 

2,921

 

 

 

2,725

 

Total stock-based compensation

 

$

2,208

 

 

$

1,498

 

 

$

5,775

 

 

$

5,225

 

Stock Activity and Total Number of Shares Available for Grant

The following table presents the stock activity and the total number of shares available for grant as of September 30, 2022:

 

 

 

(in thousands)

 

Balance at December 31, 2021

 

 

998

 

Options Cancelled

 

 

51

 

Restricted Stock Granted

 

 

(491

)

Restricted Stock Forfeited

 

 

100

 

Performance Shares Unearned

 

 

7

 

Performance Shares Granted

 

 

(167

)

Balance at September 30, 2022

 

 

498

 

Stock Option Activity

 

 

Options Outstanding

 

 

 

Number of
Shares
Underlying
Outstanding
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Outstanding at December 31, 2021

 

 

1,739,240

 

 

$

7.72

 

 

 

7.02

 

 

$

25,542,823

 

Options Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Options Exercised

 

 

(85,429

)

 

 

7.32

 

 

 

 

 

 

 

Options Forfeited

 

 

(51,038

)

 

 

9.32

 

 

 

 

 

 

 

Outstanding at September 30, 2022

 

 

1,602,773

 

 

$

7.69

 

 

 

6.17

 

 

$

2,138,611

 

Vested and expected to vest at September 30, 2022

 

 

1,593,677

 

 

$

7.76

 

 

 

6.16

 

 

$

2,133,249

 

Exercisable at September 30, 2022

 

 

1,213,781

 

 

$

7.46

 

 

 

5.79

 

 

$

1,950,309

 

Restricted stock awards  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Restricted Stock Activity

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Nonvested restricted stock at December 31, 2021

 

 

788,454

 

 

$

16.81

 

Granted

 

 

491,173

 

 

 

21.04

 

Vested

 

 

(275,229

)

 

 

16.06

 

Shares forfeited

 

 

(100,315

)

 

 

19.97

 

Nonvested restricted stock at September 30, 2022

 

 

904,083

 

 

$

18.99